drugset / Trial / NCT00319150

REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

NCT00319150

Phase 3 Terminated 6 enrolled Queen's University Ortho Biotech, Inc. · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

A strategy for optimizing erythropoietin therapy in patients with erythropoietin resistance. A multi-centered, open-label, randomized, controlled trial.

Timeline

Start
2006-10
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator epoetin alfa Protein / enzyme biologic